An innovative project of Mount Sinai Medical Center in New York City, HepCure is improving provider knowledge & patient engagement for chronic disease management in persons infected with the Hepatitis C Virus (HCV). The toolkit is designed to address barriers for the effective care and treatment of HCV by providing web-based and smartphone enabled resources, navigation, consultation, and support for both patients and providers. The HepCure toolkit draws upon the experience of expert providers within the Mount Sinai Network, with support and development by Sinai AppLab, Mount Sinai Medical Center. HepCure was developed by the Mount Sinai Division of Liver Diseases, Division of General Internal Medicine, and the Informatics for Research, Outcomes, and Quality initiative in the Division of Gastroenterology.
HepCure is a secure, cloud-based provider portal meant to virtually navigate providers through hepatitis C virus (HCV) care. The HepCure dashboard integrates tools to more effectively manage HCV infected patients. A flexible, scalable platform, the HepCure Dashboard provides a seamless flow of information within a digital healthcare infrastructure. HepCure enables easy access to HCV resources and best-practices for optimal management of HCV patients with the opportunity to engage patients on treatment, while improving overall health outcomes. The platform serves as an organizational tool, with built-in workflow efficiencies that optimize treatment decisions, reduce redundancies, as well as promote provider training and development.
Through the use of the dashboard and patient app, providers can:
We at HepCure are always looking for ways to improve. That’s why we’re constantly working on new features and meeting new challenges! Here are just a few of the features we plan to explore:
The patient app is a free resource for patients with hepatitis C, which allows them to track medication adherence, symptoms, and gain access to resources. It is available to download for free on iOS (App Store) and Android (Google Play) operating systems. While the app can be used by patients independently from the dashboard, it can also be linked with the provider dashboard. Providers can push lab data to patients and track treatment adherence and symptom data input by patients in real time.
The HepCure Tele-Education Webinar Series features many diverse and salient topics in hepatitis C. Each week, the webinar series showcases different speakers who are prominent members of the hepatitis C community. Our webinars are attended by a wide audience, and include providers, patient navigators, and other health workers from around the globe. Our collaboration with the New York State Clinical Education Initiative (CEI) and Empire Liver Foundation (ELF) allows us to provide continuing education credits (CME/CNE) through attendance to our webinars on the first and last Tuesday of every month.
All webinars are held on Tuesdays from 4:30 - 5:30pm EST
Please join us on Tuesday, May 22nd at 4:30 PM EST for a presentation by Dr. Douglas Dieterich of the Icahn School of Medicine at Mount Sinai. Dr. Dieterich will present:
“Ace the Case”
About Dr. Dieterich:
Douglas Dieterich, MD, is currently Professor of Medicine in the Division of Liver Diseases and also Director of Continuing Medical Education in the Department of Medicine at Mount Sinai School of Medicine, New York, NY. He has a triple appointment in the divisions of Liver Disease, Gastroenterology, and Infectious Diseases. He graduated from Yale University and received his Doctorate of Medicine from New York University School of Medicine. He completed his internship and residency in Internal Medicine at the Bellevue Hospital Centre in New York, NY, where he was also a Fellow in the Division of Gastroenterology. He became Clinical Assistant Professor of Medicine and then Clinical Professor of Medicine, both at New York University and remains as an Adjunct Clinical Professor of Medicine at New York University School of Medicine. Dr. Dieterich is an investigator for many ongoing clinical trials of new antiviral treatments for chronic hepatitis B & C. He is a member of many professional societies and has served on several committees of the AIDS Clinical Trials Group at the National Institutes of Health (NIH). Widely published, Dr. Dieterich is the author of numerous journal articles, abstracts and book chapters on viral hepatitis and AIDS-associated infections of the gastrointestinal tract and liver.
Please join us on Tuesday, May 15th at 4:30 PM EST for a presentation by Clifton Garmon of VOCAL-NY and Esther Mae Rosner of the Harm Reduction Coalition. Mr. Garmon & Ms. Rosner will present:
“New York State Hepatitis C Elimination Campaign Victories!”
About Mr. Garmon:
Clifton Garmon is a Senior Policy Analyst at VOCAL-NY where he monitors, examines, and promotes policies designed to improve the quality of life for marginalized communities, while engaging and educating elected officials across the state through grassroots lobbying. Clifton’s work is particularly focused on advocating for the health and wellbeing of people who use drugs, and on hepatitis C elimination throughout New York State.
About Ms. Rosner:
Esther Mae Rosner is an MSW candidate at the Silberman School of Social Work at Hunter College in New York City. Esther is in the Community Organizing, Planning & Development method with a concentration in social welfare policy. As the MSW Policy Intern at Harm Reduction Coalition, Esther has worked on the agency’s campaigns for Hepatitis C elimination, safe consumption spaces, and researching best practices for passing legislation that authorizes syringe exchange on the state level nationwide. Prior to her work at Harm Reduction Coalition, Esther has also worked as a clinician in several substance use treatment programs, and syringe exchange programs in Washington state and New York City.
These learning modules are intended for clinicians of all backgrounds who may encounter or treat patients with hepatitis C and would like to establish core competencies in screening & diagnosis, evaluation and management of the disease. Content includes screening and linkage to care, initial evaluation, diagnosis and recognition of clinical manifestations. These modules were originally presented as a component of the HepCure Tele-Education Webinar Series.
These learning modules are intended for clinicians who have experience treating patients with hepatitis C and would like to further their knowledge. These modules were originally presented as a component of the HepCure Tele-Education Webinar Series.
Psychosocial Readiness Evaluation and Preparation for Hepatitis C Treatment
THe Psychosocial Readiness Evaluation and Preparation for Hepatitis C Treatment (PREP-C) is a free interactive online tool that enables you to provide a thorough assessment of a patient’s psychosocial readiness to begin Hepatitis C treatment, and make a treatment plan to improve treatment readiness.
This free online tool can be used by any type of professional involved in preparing a patient for Hepatitis C Treatment including medical providers, nurses, mental health, substance use, social work, pharmacy, case management, treatment adherence and health education specialists.